参考文献/References:
[1]Abeler VM, Royne O, Thoresen S, et al. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients [J]. Histopathology, 2009, 54(3): 355-364.
[2]Ulrich UA, Denschlag D. Uterine adenosarcoma[J]. Oncol ResTreat, 2018, 41(11): 693-696.
[3]李海燕,宋苗苗,马欣,等.苗勒腺肉瘤56例临床分析 [J].中国实用妇科与产科杂志,2018,34(9):1047-1050.
[4]牛诤,叶骞,仝进毅,等.子宫腺肉瘤19例临床分析 [J].中国实用妇科与产科杂志,2019,35(1):127-129.
[5]夏雪薇,张贵宇,王立杰,等.子宫腺肉瘤15例临床病例分析[J].山东大学学报(医学版),2018,56(5):64-69.
[6]Seagle B, Kanis M, Strohl AE. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study[J]. Gynecol Oncol, 2016, 143(3): 636-641.
[7]Nathenson MJ, Ravi V, Fleming N, et al. Uterine adenosarcoma: a review [J]. Curr Oncol Rep, 2016, 18(11): 68.
[8]邢娟,申震,周颖,等.子宫腺肉瘤的研究进展[J].国际妇产科学杂志,2017,44(5):499-502.
[9]Carroll A, Ramirez PT, Westin SN, et al. Uterine adenosarcoma: An analysis on management, outcomes, and risk factors for recurrence [J]. Gynecol Oncol, 2014, 135(3): 455-461.
[10]李建,周怀君,凌静娴,等.子宫腺肉瘤四例报告及文献复习[J].中华妇产科杂志,2017,52(8):560-563.
[11]Lee YJ, Kim DY, Suh DS, et al. Feasibility of uterine preservation in the management of early-stage uterine adenosarcomas:a single institute experience[J]. World J Surg Oncol, 2017, 15(1): 87.
[12]Goh C, Lin XH, Chin PS, et al. Uterine preservation in a young patient with adenosarcoma of the uterus - Case report and review of literature [J]. Gynecol OncolRep,2018,25:27-29.
[13]Machida H, Nathenson MJ, Takiuchi TA, et al. Significance of lymph node metastasis on survival of women with uterine adenosarcoma [J]. Gynecol Oncol, 2017, 144(3): 524-530.
[14]Nathenson MJ, Conley AP, Lin HA, et al. The importance of lymphovascular invasion in uterine adenosarcomas analysis of clinical, prognostic, and treatment outcomes[J]. International Journal of Gynecological Cancer, 2018, 28(7): 1297-1310.
[15]Nathenson MJ, Conley AP. Prognostic factors for uterine adenosarcoma: a review [J]. Expert Rev Anticancer Ther, 2018, 18(11): 1093-1100.
[16]Bernard B, Clarke BA, Malowany JI, et al. Uterine adenosarcomas:A dual-institution update on staging,prognosis and survival [J]. Gynecol Oncol, 2013, 131(3): 634-639.
[17]Arend R, Bagaria M, Lewin SN, et al. Long-term outcome and natural history of uterine adenosarcomas[J]. Gynecol Oncol, 2010, 119(2): 305-308.
相似文献/References:
[1]王丽,曹缵孙.垂体卵泡刺激素腺瘤[J].中国计划生育和妇产科,2011,(05):0.
WANG Li,CAO Zuan-sun Maternal and Child Health Center,the First Affiliated Hospital of Medical College,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(12):0.
[2]方慧彬,冯燕.子宫颈微偏腺癌临床特点及误诊分析[J].中国计划生育和妇产科,2013,(06):0.
FNG Hui-bin,FENG Yan,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[3]徐惠琴.268例子宫肌瘤临床诊疗分析[J].中国计划生育和妇产科,2014,(07):0.
XU Hui-qin,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(12):0.
[4]周慧梅,李威,朱兰,等.妊娠期急性阑尾炎诊治进展[J].中国计划生育和妇产科,2015,(02):0.
[5]王琴*,怀莹莹,刘丽.妊娠期子宫破裂14例临床分析[J].中国计划生育和妇产科,2017,(11):50.
WANG Qin*,HUAI Ying-ying,LIU Li.Clinical analysis of 14 cases of uterine rupture during pregnancy[J].Chinese Journal of Family Planning & Gynecotokology,2017,(12):50.
[6]马晓黎,段华*.青春期生殖道畸形的临床特点与处理原则[J].中国计划生育和妇产科,2020,(3):14.
[7]汪沙,段华*.阴道斜隔综合征的诊治要点[J].中国计划生育和妇产科,2020,(3):21.